Flight Centre Travel Group Limited (ASX: FLT) upgraded its FY22 market guidance after strong travel demand globally late in the year. For the year ended 30 June 2022, the company anticipates to record an underlying EBITDA loss to be in the range of AU$180 million to AU$190 million, which driven by the increased demand after concerns about the Omicron strain abated and as governments globally eased or removed the restrictions that had grounded most non-essential travel since the start of the pandemic.
The mid-point in the new range, an underlying AU$185 million EBITDA loss, represents an 11.9% improvement on the mid-point in its initial FY22 market guidance of an underlying loss between AU$195 million and AU$225 million and a significant improvement on FLT’s AU$337.9 million FY21 underlying EBITDA loss. With the increase in demand, for FY22, the total transaction value topped AU$10 billion, which is more than two-and-a-half times the AU$3.95 billion FY21 result.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.